424 related articles for article (PubMed ID: 25350125)
1. Botulinum toxin type B: pH change reduces injection pain, retains efficacy.
Lowe PL; Lowe NJ
Dermatol Surg; 2014 Dec; 40(12):1328-33. PubMed ID: 25350125
[TBL] [Abstract][Full Text] [Related]
2. Dosing, efficacy and safety plus the use of computerized photography for botulinum toxins type A for upper facial lines.
Lowe NJ; Shah A; Lowe PL; Patnaik R
J Cosmet Laser Ther; 2010 Apr; 12(2):106-11. PubMed ID: 20151785
[TBL] [Abstract][Full Text] [Related]
3. Investigating the efficacy of vibration anesthesia to reduce pain from cosmetic botulinum toxin injections.
Sharma P; Czyz CN; Wulc AE
Aesthet Surg J; 2011 Nov; 31(8):966-71. PubMed ID: 22001341
[TBL] [Abstract][Full Text] [Related]
4. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study.
Güleç AT
J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):314-8. PubMed ID: 21492253
[TBL] [Abstract][Full Text] [Related]
5. A pilot study of botulinum toxin for interstitial cystitis/painful bladder syndrome.
Gottsch HP; Miller JL; Yang CC; Berger RE
Neurourol Urodyn; 2011 Jan; 30(1):93-6. PubMed ID: 20589903
[TBL] [Abstract][Full Text] [Related]
6. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing.
Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Moore D
J Cosmet Laser Ther; 2002 Mar; 4(1):15-8. PubMed ID: 12079632
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type B for dynamic glabellar rhytides refractory to botulinum toxin type A.
Alster TS; Lupton JR
Dermatol Surg; 2003 May; 29(5):516-8. PubMed ID: 12752520
[TBL] [Abstract][Full Text] [Related]
9. A pilot study of botulinum toxin A for male chronic pelvic pain syndrome.
Gottsch HP; Yang CC; Berger RE
Scand J Urol Nephrol; 2011 Feb; 45(1):72-6. PubMed ID: 21062115
[TBL] [Abstract][Full Text] [Related]
10. Improvement in pelvic pain with botulinum toxin type A - Single vs. repeat injections.
Nesbitt-Hawes EM; Won H; Jarvis SK; Lyons SD; Vancaillie TG; Abbott JA
Toxicon; 2013 Mar; 63():83-7. PubMed ID: 23220489
[TBL] [Abstract][Full Text] [Related]
11. Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome.
Kamanli A; Kaya A; Ardicoglu O; Ozgocmen S; Zengin FO; Bayik Y
Rheumatol Int; 2005 Oct; 25(8):604-11. PubMed ID: 15372199
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-masked, crossover comparison of the efficacy and safety of botulinum toxin type A produced from the original bulk toxin source and current bulk toxin source for the treatment of cervical dystonia.
Naumann M; Yakovleff A; Durif F;
J Neurol; 2002 Jan; 249(1):57-63. PubMed ID: 11954869
[TBL] [Abstract][Full Text] [Related]
13. An in vivo analysis of the effect and duration of treatment with botulinum toxin type A using digital image speckle correlation.
Bhatnagar D; Conkling N; Rafailovich M; Phillips BT; Bui DT; Khan SU; Dagum AB
Skin Res Technol; 2013 Aug; 19(3):220-9. PubMed ID: 23565582
[TBL] [Abstract][Full Text] [Related]
14. Treatment of acute dysmenorrhoea and pelvic pain syndrome of uterine origin with myometrial botulinum toxin injections under hysteroscopy: A pilot study.
Bautrant E; Franké O; Amiel C; Bensousan T; Thiers-Bautrant D; Levêque C
J Gynecol Obstet Hum Reprod; 2021 Apr; 50(4):101972. PubMed ID: 33186771
[TBL] [Abstract][Full Text] [Related]
15. A preliminary study of painless and effective transdermal botulinum toxin A delivery by jet nebulization for treatment of primary hyperhidrosis.
Iannitti T; Palmieri B; Aspiro A; Di Cerbo A
Drug Des Devel Ther; 2014; 8():931-5. PubMed ID: 25075176
[TBL] [Abstract][Full Text] [Related]
16. Eyebrow height after botulinum toxin type A to the glabella.
Carruthers A; Carruthers J
Dermatol Surg; 2007 Jan; 33(1 Spec No.):S26-31. PubMed ID: 17241411
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin A and B: a comparative dosing study for spasmodic dysphonia.
Blitzer A
Otolaryngol Head Neck Surg; 2005 Dec; 133(6):836-8. PubMed ID: 16360499
[TBL] [Abstract][Full Text] [Related]
18. Further studies using higher doses of botulinum toxin type F for torticollis resistant to botulinum toxin type A.
Houser MK; Sheean GL; Lees AJ
J Neurol Neurosurg Psychiatry; 1998 May; 64(5):577-80. PubMed ID: 9598669
[TBL] [Abstract][Full Text] [Related]
19. A preliminary comparison of the efficacy and tolerability of botulinum toxin serotypes A and B in the treatment of myofascial pain syndrome: a retrospective, open-label chart review.
Lang AM
Clin Ther; 2003 Aug; 25(8):2268-78. PubMed ID: 14512133
[TBL] [Abstract][Full Text] [Related]
20. An overview of the cosmetic treatment of facial muscles with a new botulinum toxin.
Wiest LG
Acta Dermatovenerol Croat; 2009; 17(1):48-53. PubMed ID: 19386215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]